article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Amendments Could Delay Passing Of Greek Medical Cannabis Bill Until Next Year

Cannabis Law Report

In May this year the Greek Parliament passed the draft production, extraction and distribution of final products of pharmaceutical cannabis of the species Cannabis Sativa containing over 0.2% Tetrahydrocannabinol (THC).

Sativa 105
article thumbnail

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration with the University of California, Davis

Cannabis Law Report

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

article thumbnail

New Zealand – 3 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard

Cannabis Law Report

MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg. Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg.

article thumbnail

Alert: NZ Ministry of Health 17 12 2021: Medicinal cannabis products that meet the minimum quality standard

Cannabis Law Report

MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg. Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg.

article thumbnail

New Study From UNM Shows Full Spectrum Hemp Oil Effective in Treating Chronic Neuropathic Pain

MedicalJane

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. This allowed the researchers to examine how “full-spectrum” whole plant extracted hemp oil influences brief episodes of pain sensitivity to an affected region. Westlund, Department of Anesthesiology.

Oil 100